Opko Health, Inc. (NYSE:OPK)

CAPS Rating: 2 out of 5

Recs

5
Player Avatar TMFBlacknGold (98.91) Submitted: 2/2/2013 12:02:57 PM : Underperform Start Price: $6.81 OPK Score: -1.92

I see a lot of speculation here about a buyout, but let's get back to reality. It doesn't seem likely that any company will pay over $2 billion for just $170 million in net assets and less than $40 million in annual revenue. Opko goes from a measly $5-$6 million in quarterly revenue to $11 and all of a sudden its the best company ever? Look closer and you'll see that a near doubling in revenue resulted in an even larger loss than last year!

Featured Broker Partners


Advertisement